Viewing Study NCT01625234

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:20 AM

Ignite Modification Date: 2025-12-27 @ 10:52 PM

Study NCT ID: NCT01625234

Status: COMPLETED

Last Update Posted: 2021-10-06

First Post: 2012-06-15

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

Sponsor: Xcovery Holdings, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Annotation Module